Trademarkia Logo

Canada

C$
TRILLEON PHARMACEUTICALS
ABANDONED SECTION 36

on 10 Dec 2019

Last Applicant/ Owned by

SYNTHETIC BIOLOGICS INC.

Suite 2709605 Medical Center DriveRockville, MD 20850

US

Serial Number

1854630 filed on 28th Aug 2017

Correspondent Address

SMART & BIGGAR LP

SCOTIA PLAZA40 KING STREET WEST40th FLOORTORONTO

ONTARIO

CA

M5H3Y2

TRILLEON PHARMACEUTICALS

Trademark usage description

pharmaceutical preparations for the treatment, prevention and alleviation of gastrointestinal diseases, infections, dysbiosis, and disorders; pharmace Read More

Classification Information


Class [005]
Pharmaceutical preparations for the treatment, prevention and alleviation of gastrointestinal diseases, infections, dysbiosis, and disorders; pharmaceutical preparations for the treatment of metabolic diseases and disorders; pharmaceuticals, namely, pharmaceutical preparations for gastrointestinal health, gastrointestinal dysbiosis and systemic illnesses associated with gastrointestinal dysbiosis, gastrointestinal disorders and systemic illnesses associated with gastrointestinal disorders, gastrointestinal diseases and systemic illnesses associated with gastrointestinal diseases, gastrointestinal infections and systemic illnesses associated with gastrointestinal infections, used to maintain health and restore health to a human or animal subject via treatment of a disturbed microbial community and prevention of microbial community disruption


Classification kind code

11

Mark Details


Serial Number

1854630

Mark Type

Trademark

Legal History


Action TakenStatus
Submitted for opposition 6
on 10th Dec 2019
Abandoned - Section 36
Submitted for opposition 14
on 17th Sept 2019
Default Notice Sent
Submitted for opposition 12
on 15th Mar 2019
Extension of Time
Submitted for opposition 22
on 27th Aug 2018
Search Recorded
Submitted for opposition 20
on 27th Aug 2018
Examiner's First Report
Submitted for opposition 31
on 30th Aug 2017
Formalized
Submitted for opposition 30
on 28th Aug 2017
Filed
Submitted for opposition 1
on 28th Aug 2017
Created